About
Serenus.AI specializes in the development of advanced Generative AI technologies that empower medical decisions at critical medical crossroads on patient pathways, saving lives and valuable resources. Our flagship product is the first (registered patent and 4 patents pending) clinically objective, Generative AI, automated case-by-case system to improve decision-making before medical procedures and treatments, while prioritizing patients' waiting lists. Serenus.AI advanced the quality and equality of healthcare delivery, saves valuable resources, and boosts patients', physicians', and payers' satisfaction across the board.
The system's algorithms replicate the objective decision-making processes of top physicians by combining up-to-date medical practices, professional knowledge, and machine-learning technologies.
The Serenus.AI solution is compatible with every type of health system, including US insurance companies and public health systems. The solution has been validated in practice, and the company is currently active in Europe and the United States with stakeholders in the healthcare field.
Funding history · 1 round · $2.7M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Serenus.AI founded and where is its headquarters located?
- Serenus.AI was founded in March 2017 and is headquartered in Tel Aviv-Yafo, Israel.
- What is Serenus.AI's primary focus in terms of technology and application?
- Serenus.AI specializes in developing Generative AI technologies to improve medical decision-making for treatment pathways and patient waiting lists.
- What was Serenus.AI's total funding raised and when was its last funding round?
- Serenus.AI has raised a total of $2.7 million. Its last funding round was a Seed round in July 2018, which raised $1.9 million with investors including Firstime VC and thetime. For a full financing history, refer to startupim.
- Has Serenus.AI received any grants?
- Yes, Serenus.AI received an $800,000 grant from the IIA in July 2020.
- What is the current employee count for Serenus.AI?
- Serenus.AI currently has 5 employees.
- What significant intellectual property does Serenus.AI hold?
- In May 2021, Serenus.AI was granted a US patent for an 'AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES'. The company also has 4 patents pending.
- Which company did Serenus.AI partner with to innovate the authorization process?
- In September 2020, Serenus.AI teamed up with HealthTrio to innovate the authorization process using advanced machine learning.
- In which geographic markets is Serenus.AI currently active?
- Serenus.AI is active in the United Kingdom, Europe, the United States, and Israel.